Competitive Intelligence Analyst jobs in United States
cer-icon
Apply on Employer Site
company-logo

Caris Life Sciences · 2 weeks ago

Competitive Intelligence Analyst

Caris Life Sciences is focused on transforming cancer care through precision medicine and cutting-edge molecular science. The Competitive Intelligence Analyst will generate actionable insights on the competitive landscape for next-generation sequencing-based diagnostic testing, supporting strategic decision-making across various departments.

Artificial Intelligence (AI)BiopharmaBiotechnologyHealth CareLife Science

Responsibilities

Continuously monitor competitors in the precision oncology diagnostics space, including new test launches, regulatory filings, clinical validation studies, partnerships, pricing, and reimbursement strategies
Conduct in-depth analysis of emerging technologies (e.g., liquid biopsy, companion diagnostics, multi-cancer early detection) and their potential impact
Develop profiles and benchmarking reports on key competitors, products, and pipelines
Deliver monthly and quarterly intelligence summaries, competitive dashboards, and scenario analyses to inform strategic and tactical planning
Understand business implications of complex scientific and market data
Contribute quarterly competitive landscape reviews, ad-hoc deep dives, and strategic discussions
Translate findings into strategic recommendations for executive and functional leadership to guide portfolio prioritization, go-to-market, and evidence generation strategies
Partner with R&D, Commercial, and Medical Affairs to monitor clinical trial results, publications, and congress updates relevant to cancer diagnostics
Collaborate with Market Access and Reimbursement teams to track payer policies, coverage decisions, and competitor pricing
Support Business Development with competitive intelligence for partnerships, licensing opportunities, and M&A assessments
Actively participate in cross-functional working groups, competitive review meetings, and major congress debriefs (ASCO, ESMO, AMP, etc.)
Leverage databases, publications, analyst reports, KOL input, and primary/secondary research to build robust intelligence deliverables
Implement AI tools to increase effectiveness and efficiency of intelligence gathering, consolidation, and analysis
Maintain a centralized repository of competitive intelligence and establish best practices for dissemination across the company

Qualification

Competitive intelligenceMarket analysisData integrationNGS technologiesAnalytical skillsCI tools proficiencyMicrosoft Office SuiteHigh integrityCommunication skillsProject management

Required

Bachelor's degree in Life Sciences, Oncology, Molecular Biology, Genetics, or related field required
3–5 years of experience in competitive intelligence or market analysis within diagnostics, biotech, or life sciences
Experience integrating data from multiple sources (e.g., publications, regulatory databases, KOL interviews) into cohesive strategic narratives
Strong understanding of the competitive dynamics among precision oncology companies (e.g., Caris, Foundation Medicine, Guardant, Tempus, Exact Sciences)
Proficient in Microsoft Office Suite, specifically Word, Excel, Outlook, and general working knowledge of Internet for business use
Strong analytical skills with the ability to synthesize complex technical and business information into actionable insights
Proficiency in CI tools, market databases, and data visualization platforms
Self-starter with ability to manage multiple projects, prioritize under deadlines, and work independently
High integrity and ability to handle confidential information appropriately
Excellent communication skills (written, verbal, and presentation)

Preferred

Advanced degree (MS, PhD, MBA) preferred
Familiarity with NGS technologies, clinical oncology applications, and the regulatory landscape for diagnostics is strongly preferred

Company

Caris Life Sciences

company-logo
Caris Life Sciences develops molecular profiling and AI-driven technologies to support precision medicine in oncology.

Funding

Current Stage
Public Company
Total Funding
$1.86B
Key Investors
BraidwellOrbiMedSixth Street
2025-06-18IPO
2025-04-07Private Equity· $168M
2023-01-19Debt Financing· $400M

Leadership Team

leader-logo
Luke Power
Chief Financial Officer
linkedin
leader-logo
Brian Stengle
SVP, Chief Marketing Officer
linkedin
Company data provided by crunchbase